Find a doctor 
Contact us 
The parents of a 15-year-old boy were referred to the Yeolyan Hematology and Oncology Center by a neurologist due to a marked decrease in sensation in the lower extremities, numbness, and tingling. The disease course was characterized by progressive muscle weakness, which gradually ascended from the limbs upward. Symptoms were symmetrical, affecting both extremities simultaneously, resulting in significant gait disturbance and markedly diminished reflexes.
Diagnosis
The patient was diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Pharmacologic treatment was initially administered; however, the desired clinical response was not achieved. Therapeutic plasmapheresis was subsequently indicated by the neurologist, as it is considered a first-line treatment for this diagnosis.
In CIDP, the myelin sheath surrounding nerve fibers is damaged, disrupting the transmission of signals from the brain to the muscles.
Through apheresis-based plasmapheresis, plasma containing pathogenic antibodies that damage the nervous system is removed from the patient’s blood. The purified blood is then returned to circulation, helping halt further myelin destruction.
A total of 10 therapeutic plasmapheresis sessions were performed, followed by pharmacologic treatment.
Significant positive clinical improvement was observed during plasmapheresis, and by the completion of treatment, symptoms had nearly resolved. As a result:
The progression of the disease was halted,
lower limb sensation was restored,
Motor activity and gait significantly improved.
Therapeutic plasmapheresis is considered a first-line treatment modality in a range of diseases.
Gait Disturbance and Reduced Lower Limb Reflexes in an Adolescent: Positive Impact of Therapeutic Plasmapheresis
The parents of a 15-year-old boy were referred to the Yeolyan Hematology and Oncology Center by a neurologist due to a marked decrease in sensation in the lower extremities, numbness, and tingling. The disease course was characterized by progressive muscle weakness, which gradually ascended from the limbs upward. Symptoms were symmetrical, affecting both extremities simultaneously, …
Head of the Pediatric Oncology Department, Ruzanna Papyan, Successfully Defends PhD Dissertation
Ruzanna Papyan, Head of the Pediatric Oncology Department at the Yeolyan Hematology and Oncology Center, has successfully defended her PhD dissertation titled: “Predictive Factors of Survival in Children and Adolescents with Musculoskeletal Sarcomas in Armenia.” The study presents data on patients’ clinical course and treatment outcomes, as well as clearly assessed survival indicators. In particular, …
Bone Marrow Transplantation
Over the past week, three new opportunities for life became a reality at our Center: two allogeneic and one autologous bone marrow transplants were successfully performed. For us, this is more than a medical procedure — it is a shared fight in which our team stands beside every patient in pursuit of health and improved …
Advancing Local Practice Through Global Expertise: The Yeolyan Center Continues to Host Leading Specialists
The Yeolyan Hematology and Oncology Center welcomed Professor Stefan Bielack, a German pediatric hematologist-oncologist and Head of the Department of Pediatric Oncology, Hematology, and Immunology at Klinikum Stuttgart. During the visit, the Center’s specialists presented Professor Bielack with the workflows and infrastructure of the pediatric departments. He also visited the Pediatric Palliative Care Center, where …
ACT for Children Delegation Visits Pediatric Department at the Yeolyan Center
Specialists of the Yeolyan Hematology and Oncology Center presented the visiting ACT for Children delegation with an overview of programs, services, and development priorities in pediatric oncology. Through a series of presentations, the delegation was introduced to the structure of services, patient flow, current diagnostic and treatment pathways, as well as the capacities of nursing …
High-Cost Immunotherapeutic Medications to Be Provided to Armenia within the ACT for Children Initiative
The “Yolyan” Hematology and Oncology Center, in collaboration with the City of Smile Charitable Foundation, hosted a delegation visiting Armenia within the framework of the ACT for Children initiative. Since 2024, Armenia has been the first partner country to join the international ACT for Children initiative, aimed at advancing pediatric hematology and oncology services and …
Arpi’s Big Victory: Acute Lymphoblastic Leukemia Defeated
Six-year-old Arpi was diagnosed with acute lymphoblastic leukemia (ALL) two years ago. This was followed by a prolonged course of treatment at the “Yolyan” Hematology and Oncology Center. Now, having completed both the intensive and maintenance phases of therapy, Arpi rings the bell marking the end of her treatment. Throughout this journey, the family received …
Early Detection Is One of the Most Effective Ways to Fight Cancer/ Astghik Voskanyan, Lianna Safaryan / Public Radio
The moment a person learns about a cancer diagnosis, their life—and the lives of their loved ones—changes completely. Early detection is one of the most effective ways to fight cancer. It significantly increases the chances of successful treatment and saves lives. Your health begins with informed decisions. As part of World Cancer Day, the guests …
Stem Cell Collection for Transplantation
Hematopoietic stem cells are the primary cells of the blood-forming system, from which all blood elements originate. Under normal conditions, they reside in the bone marrow; however, following administration of specific mobilizing agents, they temporarily enter the peripheral bloodstream. At this stage, stem cell collection from peripheral blood is performed. Stem cell transplantation is …
